<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=(0061)http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html -->
<HTML><HEAD><TITLE>MedlinePlus Drug Information: Cephalosporins (Systemic)</TITLE>
<META http-equiv=Content-Type content="text/html; charset=utf-8">
<META content="Cephalosporins (Systemic)" name=description>
<META 
content="Cephalosporins (Systemic), Ancef, Ceclor, Ceclor CD, Cedax, Cefadyl, Cefditoren, Cefizox, Cefobid, Cefotan, Ceftin, Cefzil, Ceptaz, Claforan, Duricef, Fortaz, Keflex, Keftab, Kefurox, Kefzol, Mandol, Maxipime, Mefoxin, Monocid, Omnicef, Rocephin, Tazicef, Tazidime, Vantin, Velosef, Zinacef, Ancef, Apo-Cefaclor, Apo-Cephalex, Ceclor, Cefizox, Cefotan, Ceftin, Cefzil, Ceporacin, Ceptaz, Claforan, Duricef, Fortaz, Keflex, Keflin, Kefurox, Kefzol, Mandol, Maxipime, Mefoxin, Novo-Lexin, Nu-Cephalex, PMS-Cephalexin, Rocephin, Suprax, Tazidime, Zinacef, Cefaclor, Cefadroxil , Cefamandole, Cefazolin, Cefdinir ,  Cefepime,  Cefixime, Cefditoren, Cefonicid , Cefoperazone,  Cefotaxime, Cefotetan, Cefoxitin , Cefpodoxime, Cefprozil , Ceftazidime, Ceftibuten ,  Ceftizoxime, Ceftriaxone,  Cefuroxime, Cephalexin, Cephalothin , Cephapirin,  Cephradine" 
name=keywords><LINK title="The Dublin Core metadata Element Set" 
href="http://purl.org/dc/elements/1.1/" rel=schema.DC>
<META content="Cephalosporins (Systemic)" name=DC.Title>
<META content=Ancef name=DC.Title.Alternate>
<META content=Ceclor name=DC.Title.Alternate>
<META content="Ceclor CD" name=DC.Title.Alternate>
<META content=Cedax name=DC.Title.Alternate>
<META content=Cefadyl name=DC.Title.Alternate>
<META content=Cefditoren name=DC.Title.Alternate>
<META content=Cefizox name=DC.Title.Alternate>
<META content=Cefobid name=DC.Title.Alternate>
<META content=Cefotan name=DC.Title.Alternate>
<META content=Ceftin name=DC.Title.Alternate>
<META content=Cefzil name=DC.Title.Alternate>
<META content=Ceptaz name=DC.Title.Alternate>
<META content=Claforan name=DC.Title.Alternate>
<META content=Duricef name=DC.Title.Alternate>
<META content=Fortaz name=DC.Title.Alternate>
<META content=Keflex name=DC.Title.Alternate>
<META content=Keftab name=DC.Title.Alternate>
<META content=Kefurox name=DC.Title.Alternate>
<META content=Kefzol name=DC.Title.Alternate>
<META content=Mandol name=DC.Title.Alternate>
<META content=Maxipime name=DC.Title.Alternate>
<META content=Mefoxin name=DC.Title.Alternate>
<META content=Monocid name=DC.Title.Alternate>
<META content=Omnicef name=DC.Title.Alternate>
<META content=Rocephin name=DC.Title.Alternate>
<META content=Tazicef name=DC.Title.Alternate>
<META content=Tazidime name=DC.Title.Alternate>
<META content=Vantin name=DC.Title.Alternate>
<META content=Velosef name=DC.Title.Alternate>
<META content=Zinacef name=DC.Title.Alternate>
<META content=Ancef name=DC.Title.Alternate>
<META content=Apo-Cefaclor name=DC.Title.Alternate>
<META content=Apo-Cephalex name=DC.Title.Alternate>
<META content=Ceclor name=DC.Title.Alternate>
<META content=Cefizox name=DC.Title.Alternate>
<META content=Cefotan name=DC.Title.Alternate>
<META content=Ceftin name=DC.Title.Alternate>
<META content=Cefzil name=DC.Title.Alternate>
<META content=Ceporacin name=DC.Title.Alternate>
<META content=Ceptaz name=DC.Title.Alternate>
<META content=Claforan name=DC.Title.Alternate>
<META content=Duricef name=DC.Title.Alternate>
<META content=Fortaz name=DC.Title.Alternate>
<META content=Keflex name=DC.Title.Alternate>
<META content=Keflin name=DC.Title.Alternate>
<META content=Kefurox name=DC.Title.Alternate>
<META content=Kefzol name=DC.Title.Alternate>
<META content=Mandol name=DC.Title.Alternate>
<META content=Maxipime name=DC.Title.Alternate>
<META content=Mefoxin name=DC.Title.Alternate>
<META content=Novo-Lexin name=DC.Title.Alternate>
<META content=Nu-Cephalex name=DC.Title.Alternate>
<META content=PMS-Cephalexin name=DC.Title.Alternate>
<META content=Rocephin name=DC.Title.Alternate>
<META content=Suprax name=DC.Title.Alternate>
<META content=Tazidime name=DC.Title.Alternate>
<META content=Zinacef name=DC.Title.Alternate>
<META content=Cefaclor name=DC.Title.Alternate>
<META content=Cefadroxil name=DC.Title.Alternate>
<META content=Cefamandole name=DC.Title.Alternate>
<META content=Cefazolin name=DC.Title.Alternate>
<META content=Cefdinir name=DC.Title.Alternate>
<META content=Cefepime name=DC.Title.Alternate>
<META content=Cefixime name=DC.Title.Alternate>
<META content=Cefditoren name=DC.Title.Alternate>
<META content=Cefonicid name=DC.Title.Alternate>
<META content=Cefoperazone name=DC.Title.Alternate>
<META content=Cefotaxime name=DC.Title.Alternate>
<META content=Cefotetan name=DC.Title.Alternate>
<META content=Cefoxitin name=DC.Title.Alternate>
<META content=Cefpodoxime name=DC.Title.Alternate>
<META content=Cefprozil name=DC.Title.Alternate>
<META content=Ceftazidime name=DC.Title.Alternate>
<META content=Ceftibuten name=DC.Title.Alternate>
<META content=Ceftizoxime name=DC.Title.Alternate>
<META content=Ceftriaxone name=DC.Title.Alternate>
<META content=Cefuroxime name=DC.Title.Alternate>
<META content=Cephalexin name=DC.Title.Alternate>
<META content=Cephalothin name=DC.Title.Alternate>
<META content=Cephapirin name=DC.Title.Alternate>
<META content=Cephradine name=DC.Title.Alternate>
<META content="United States Pharmacopeia" name=DC.Publisher>
<META content=eng name=DC.Language>
<META content=http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html 
name=DC.Identifier.URL>
<META content="Sun, 04 Mar 2007 16:04:04 GMT" name=expires><LINK 
href="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/stylesheet.css" 
type=text/css rel=STYLESHEET><LINK href="/medlineplus/images/favicon.ico/" 
type=image/x-icon rel="shortcut icon">
<STYLE type=text/css>@import url( /medlineplus/images/advanced.css );
</STYLE>

<SCRIPT language=JavaScript type=text/javascript>
<!--
        //break out of framing sites
        if (top.location != self.location)
        {
                top.location = 'http://www.nlm.nih.gov/medlineplus/framing.html';
        }
-->
</SCRIPT>

<SCRIPT language=JavaScript>
	<!--//
	var imageNames=new Object;
	
	var imagePath="/medlineplus/images";
	var langExt="";
	
	if (document.images)   {
	        
	        	imageNames["home"]="home";
	                imageNames["healthtopics"]="healthtopics";
	                 
	                imageNames["druginformation"]="druginformation";
	                 
	                imageNames["encyclopedia"]="encyclopedia";
	                 
	                imageNames["dictionary"]="dictionary";
	                 
	                imageNames["news"]="news";
	                 
	                imageNames["directories"]="directories";
	                 
	                imageNames["otherresources"]="otherresources";
	                 
	}
//-->
</SCRIPT>

<SCRIPT 
src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/static.js" 
type=text/javascript>
	       
</SCRIPT>
<!--
   Javascript for the english survey,
   runs at least through FY 2004.
   Do Not Remove without coordinating with LO
-->
<SCRIPT 
src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/mplus_en_survey.js" 
type=text/javascript></SCRIPT>
<!-- End Survey Code -->
<META content="MSHTML 6.00.2900.3020" name=GENERATOR></HEAD>
<BODY text=#000000 vLink=#660000 aLink=#660000 link=#660099 bgColor=#ffffff 
topMargin=0 MARGINHEIGHT="0">
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
  <TBODY>
  <TR>
    <TD class=minusTwo colSpan=3><A 
      title="Skip navigation links and go to the page content" 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#skip">Skip 
      navigation</A> </TD></TR>
  <TR>
    <TD vAlign=top align=left width=325><A href="http://medlineplus.gov/"><IMG 
      title="MedlinePlus Trusted Health Information for You" height=65 
      alt="MedlinePlus Trusted Health Information for You" 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/druginformation_banner.gif" 
      width=325 border=0></A></TD>
    <TD vAlign=top align=left width="100%" 
    background="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/2banner_slice.gif" 
    height=65><IMG title="" height=65 alt="" 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/2banner_slice.gif" 
      width="100%" border=0></TD>
    <TD vAlign=top align=left><IMG height=65 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/medlineplus_secondary.gif" 
      width=425 useMap=#nlmnih border=0><MAP name=nlmnih><AREA 
        title="U.S. National Library of Medicine" onclick="openOutWin('')" 
        shape=RECT target=TheNewWin alt="U.S. National Library of Medicine" 
        coords=200,14,420,25 
        href="http://www.nlm.nih.gov/cgi/medlineplus/leavemedplus.pl?theURL=http%3A%2F%2Fwww%2Enlm%2Enih%2Egov"><AREA 
        title="National Institutes of Health" onclick="openOutWin('')" 
        shape=RECT target=TheNewWin alt="National Institutes of Health" 
        coords=219,35,419,45 
        href="http://www.nlm.nih.gov/cgi/medlineplus/leavemedplus.pl?theURL=http%3A%2F%2Fwww%2Enih%2Egov"></MAP></TD></TR>
  <TR>
    <TD vAlign=center bgColor=#fffaea colSpan=3>
      <DIV align=left>
      <FORM id=form1 title="Site Search input" 
      style="FLOAT: left; MARGIN: 1px; WIDTH: 320px" name=form1 
      action=http://search.nlm.nih.gov/medlineplus/query method=get 
      target=_self><INPUT type=hidden value=true name=DISAMBIGUATION> <INPUT 
      type=hidden value=search name=FUNCTION> <INPUT type=hidden value=server2 
      name=SERVER2> <INPUT type=hidden value=server1 name=SERVER1> <INPUT 
      maxLength=250 name=PARAMETER> <INPUT title="Search MedlinePlus" type=image 
      height=24 alt="Search MedlinePlus" width=130 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/search_medplus.gif" 
      align=absMiddle border=0> </FORM></DIV>
      <DIV><A 
      href="http://www.nlm.nih.gov/cgi/medlineplus/feedback.pl?from=%2Fmedlineplus%2Fdruginformation%2Ehtml&amp;lang=EN"><IMG 
      title="Contact Us" height=24 alt="Contact Us" 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/contactus.gif" 
      width=67 align=right border=0></A> <A 
      href="http://www.nlm.nih.gov/medlineplus/faq/faq.html"><IMG title=FAQs 
      height=24 alt=FAQs hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/faq.gif" 
      width=39 align=right border=0></A> <A 
      href="http://www.nlm.nih.gov/medlineplus/sitemap.html"><IMG 
      title="Site Map" height=24 alt="Site Map" 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/sitemap.gif" 
      width=56 align=right border=0></A> <A 
      href="http://www.nlm.nih.gov/medlineplus/aboutmedlineplus.html"><IMG 
      title="About MedlinePlus" height=24 alt="About MedlinePlus" hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/about.gif" 
      width=112 align=right border=0></A> </DIV>
      <DIV></DIV></TD></TR>
  <TR>
    <TD vAlign=top align=left width="100%" bgColor=#330066 colSpan=3><IMG 
      title="" height=1 alt="" 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/clear.gif" 
      width="100%" border=0></TD></TR>
  <TR>
    <TD colSpan=3>
      <FORM title="Health Categories Tabs" name=imgForm action=""><A 
      href="http://www.nlm.nih.gov/medlineplus/spanish/sorrydrugs.html"><IMG 
      title=español height=22 alt=español hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/espanol.gif" 
      width=71 align=right border=0></A> <A onmouseover="depress('home');" 
      onmouseout="unpress('home');" href="http://medlineplus.gov/"><IMG 
      title=Home height=22 alt=Home hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/home_button1.gif" 
      width=41 align=left border=0 name=home></A> <A 
      onmouseover="depress('healthtopics');" 
      onmouseout="unpress('healthtopics');" 
      href="http://www.nlm.nih.gov/medlineplus/healthtopics.html"><IMG 
      title="Health Topics" height=22 alt="Health Topics" hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/healthtopics_button1.gif" 
      align=left border=0 name=healthtopics></A> <A 
      href="http://www.nlm.nih.gov/medlineplus/druginformation.html"><IMG 
      title="Drugs &amp; Supplements" height=22 alt="Drugs &amp; Supplements" 
      hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/druginformation_button2.gif" 
      align=left border=0 name=druginformation></A> <A 
      onmouseover="depress('encyclopedia');" 
      onmouseout="unpress('encyclopedia');" 
      href="http://www.nlm.nih.gov/medlineplus/encyclopedia.html"><IMG 
      title="Medical Encyclopedia" height=22 alt="Medical Encyclopedia" hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/encyclopedia_button1.gif" 
      align=left border=0 name=encyclopedia></A> <A 
      onmouseover="depress('dictionary');" onmouseout="unpress('dictionary');" 
      href="http://www.nlm.nih.gov/medlineplus/mplusdictionary.html"><IMG 
      title=Dictionary height=22 alt=Dictionary hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/dictionary_button1.gif" 
      align=left border=0 name=dictionary></A> <A onmouseover="depress('news');" 
      onmouseout="unpress('news');" 
      href="http://www.nlm.nih.gov/medlineplus/newsbydate.html"><IMG title=News 
      height=22 alt=News hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/news_button1.gif" 
      align=left border=0 name=news></A> <A 
      onmouseover="depress('directories');" onmouseout="unpress('directories');" 
      href="http://www.nlm.nih.gov/medlineplus/directories.html"><IMG 
      title=Directories height=22 alt=Directories hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/directories_button1.gif" 
      align=left border=0 name=directories></A> <A 
      onmouseover="depress('otherresources');" 
      onmouseout="unpress('otherresources');" 
      href="http://www.nlm.nih.gov/medlineplus/otherresources.html"><IMG 
      title="Other Resources" height=22 alt="Other Resources" hspace=0 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/otherresources_button1.gif" 
      align=left border=0 name=otherresources></A> 
</FORM></TD></TR></TBODY></TABLE><BR><A name=skip></A>
<DIV class=minusOne>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
  <TBODY>
  <TR>
    <TD width="100%" colSpan=2 height=15></TD></TR>
  <TR>
    <TD class=minusOne vAlign=top align=left 
      width=*>Other&nbsp;drug&nbsp;names:&nbsp; </TD>
    <TD class=minusOne vAlign=top align=left width="100%"><A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Aa.html">A-Am</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_An.html">An-Az</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ba.html">B</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ca.html">C-Ch</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ci.html">Ci-Cz</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Da.html">D-Dh</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Di.html">Di-Dz</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ea.html">E</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Fa.html">F</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ga.html">G</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ha.html">H</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ia.html">I-J</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ka.html">K-L</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ma.html">M-Mh</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Mi.html">Mi-Mz</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Na.html">N-Nh</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ni.html">Ni-Nz</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Oa.html">O</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Pa.html">P-Pl</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Pm.html">Pm-Pz</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Qa.html">Q-R</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Sa.html">S-Sn</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_So.html">So-Sz</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ta.html">T-To</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Tp.html">Tp-Tz</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ua.html">U-V</A>&nbsp; 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_Wa.html">W-Z</A>&nbsp; 
      <A href="http://www.nlm.nih.gov/medlineplus/druginfo/drug_00.html">0-9</A> 
    </TD></TR></TBODY></TABLE></DIV>
<H3>Cephalosporins&nbsp; (Systemic) </H3>
<TABLE width="100%">
  <TBODY>
  <TR>
    <TD vAlign=top height=30><A onclick="openNakedWin('PrintWin')" 
      href="http://www.nlm.nih.gov/medlineplus/print/druginfo/uspdi/202119.html" 
      target=PrintWin><IMG title="Printer-friendly version" height=25 
      alt="Printer-friendly version" 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/print_version.gif" 
      width=114 align=left border=0></A><A onclick="openNakedWin('EmailReqWin')" 
      href="http://www.nlm.nih.gov/cgi/medlineplus/email_request.pl?refPage=http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html&amp;emailTitle=Drug Information: Cephalosporins  (Systemic)" 
      target=EmailReqWin><IMG title="E-mail this page to a friend" height=25 
      alt="E-mail this page to a friend" 
      src="MedlinePlus%20Drug%20Information%20Cephalosporins%20(Systemic)_files/email_version.gif" 
      width=85 border=0></A></TD></TR></TBODY></TABLE>
<TABLE cellSpacing=0 cellPadding=3 width="100%" bgColor=#e8eff5 border=0>
  <TBODY>
  <TR>
    <TD class=minusOne vAlign=top align=left width="100%" 
      colSpan=2><STRONG>Contents of this page:</STRONG></TD></TR>
  <TR id=pageContents>
    <TD vAlign=top align=left width="50%">
      <UL><SPAN class=minusOne><!--LeftColumnBegin-->
        <LI><A 
        href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#SXX05">Description</A> 

        <LI><A 
        href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#SXX06">Before 
        Using This Medicine</A> 
        <LI><A 
        href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#SXX14">Proper 
        Use of This Medicine</A> 
        <LI><A 
        href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#SXX18">Precautions 
        While Using This Medicine</A> <!--LeftColumnEnd--></SPAN></LI></UL></TD>
    <TD class=minusOne vAlign=top align=left width="50%">
      <UL><!--RightColumnBegin-->
        <LI><A 
        href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#SXX19">Side 
        Effects of This Medicine</A> 
        <LI><A 
        href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#SXX">Additional 
        Information</A> 
        <LI><A 
        href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#Brands">Brand 
        Names</A> 
        <LI><A 
        href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#CATEGORY_SEC">Category</A> 
<!--RightColumnEnd--></SPAN></LI></UL></TD></TR></TBODY></TABLE><A 
name=SXX05></A>
<H4>Description<A class=return 
href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#skip">Return 
to top</A> </H4>
<DIV class=minusOne>
<P>Cephalosporins ( sef-a-loe-SPOR-ins) are used in the treatment of infections 
caused by bacteria. They work by killing bacteria or preventing their growth. 
<P>Cephalosporins are used to treat infections in many different parts of the 
body. They are sometimes given with other antibiotics. Some cephalosporins given 
by injection are also used to prevent infections before, during, and after 
surgery. However, cephalosporins will not work for colds, flu, or other virus 
infections.
<P>Cephalosporins are available only with your doctor's prescription, in the 
following dosage forms: 
<UL><LH><EM>Oral</EM> </LH>
  <LI>Cefaclor 
  <UL>
    <LI>Capsules (U.S. and Canada) 
    <LI>Oral suspension (U.S. and Canada) 
    <LI>Extended-release tablets (U.S.) </LI></UL>
  <LI>Cefadroxil 
  <UL>
    <LI>Capsules (U.S. and Canada) 
    <LI>Oral suspension (U.S.) 
    <LI>Tablets (U.S.) </LI></UL>
  <LI>Cefdinir
  <UL>
    <LI>Capsules (U.S.) 
    <LI>Oral Suspension (U.S.) </LI></UL>
  <LI>Cefditoren
  <UL>
    <LI>Tablets (U.S.) </LI></UL>
  <LI>Cefixime 
  <UL>
    <LI>Oral suspension (Canada) 
    <LI>Tablets (Canada)Cefixime was withdrawn from the U.S. market by Wyeth in 
    October 2002 </LI></UL>
  <LI>Cefpodoxime 
  <UL>
    <LI>Oral suspension (U.S.) 
    <LI>Tablets (U.S.) </LI></UL>
  <LI>Cefprozil 
  <UL>
    <LI>Oral suspension (U.S. and Canada) 
    <LI>Tablets (U.S. and Canada) </LI></UL>
  <LI>Ceftibuten 
  <UL>
    <LI>Capsules (U.S.) 
    <LI>Oral suspension (U.S.) </LI></UL>
  <LI>Cefuroxime 
  <UL>
    <LI>Oral suspension (U.S. and Canada) 
    <LI>Tablets (U.S. and Canada) </LI></UL>
  <LI>Cephalexin 
  <UL>
    <LI>Capsules (U.S. and Canada) 
    <LI>Oral suspension (U.S. and Canada) 
    <LI>Tablets (U.S. and Canada) </LI></UL>
  <LI>Cephradine 
  <UL>
    <LI>Capsules (U.S.) 
    <LI>Oral suspension (U.S.) </LI></UL></LI></UL>
<UL><LH><EM>Parenteral</EM> </LH>
  <LI>Cefamandole 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Cefazolin 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Cefepime 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Cefonicid 
  <UL>
    <LI>Injection (U.S.) </LI></UL>
  <LI>Cefoperazone 
  <UL>
    <LI>Injection (U.S.) </LI></UL>
  <LI>Cefotaxime 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Cefotetan 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Cefoxitin 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Ceftazidime 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Ceftizoxime 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Ceftriaxone 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Cefuroxime 
  <UL>
    <LI>Injection (U.S. and Canada) </LI></UL>
  <LI>Cephalothin 
  <UL>
    <LI>Injection (Canada) </LI></UL>
  <LI>Cephapirin 
  <UL>
    <LI>Injection (U.S.) </LI></UL></LI></UL></DIV><BR><BR><A name=SXX06></A>
<H4>Before Using This Medicine<A class=return 
href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#skip">Return 
to top</A> </H4>
<DIV class=minusOne>
<P>In deciding to use a medicine, the risks of taking the medicine must be 
weighed against the good it will do. This is a decision you and your doctor will 
make. For the cephalosporins, the following should be considered:
<P><STRONG>Allergies—</STRONG>Tell your doctor if you have ever had any unusual 
or allergic reaction to any of the cephalosporins, penicillins, penicillin-like 
medicines, or penicillamine. Also tell your health care professional if you are 
allergic to any other substances, such as foods, preservatives, or dyes. </P>
<P><STRONG>Pregnancy—</STRONG>Studies have not been done in humans. However, 
most cephalosporins have not been reported to cause birth defects or other 
problems in animal studies. Studies in rabbits have shown that cefoxitin may 
increase the risk of miscarriages and cause other problems.</P>
<P><STRONG>Breast-feeding—</STRONG>It is not known if cefditoren passes into 
breast milk. Most cephalosporins pass into breast milk, usually in small 
amounts. However, cephalosporins have not been reported to cause problems in 
nursing babies.</P>
<P><STRONG>Children—</STRONG>Many cephalosporins have been tested in children 
and, in effective doses, have not been shown to cause different side effects or 
problems than they do in adults. However, there are some cephalosporins that 
have not been tested in children up to 12 year of age.</P>
<P><STRONG>Older adults—</STRONG>Cephalosporins have been used in the elderly, 
and they are not expected to cause different side effects or problems in older 
people than they do in younger adults.</P>
<P><STRONG>Other medicines—</STRONG>Although certain medicines should not be 
used together at all, in other cases two different medicines may be used 
together even if an interaction might occur. In these cases, your doctor may 
want to change the dose, or other precautions may be necessary. When you are 
taking a cephalosporin, it is especially important that your health care 
professional know if you are taking any of the following: 
<UL>
  <LI>Alcohol or alcohol-containing medicine (cefamandole, cefoperazone, and 
  cefotetan only)—Using alcohol and these cephalosporins together may cause 
  abdominal or stomach cramps, nausea, vomiting, headache, dizziness or 
  light-headedness, shortness of breath, sweating, or facial flushing; this 
  reaction usually begins within 15 to 30 minutes after alcohol is consumed and 
  usually goes away over several hours </LI></UL>
<UL>
  <LI>Aminoglycoside antibiotics, such asAmikacin (e.g., Amikin) orGentamicin 
  (e.g., Apogen) orNeomycin (e.g., Mycifradin)— use with cefuroxime may result 
  in increased chance of serious side effects </LI></UL>
<UL>
  <LI>Anticoagulants (blood thinners) or 
  <LI>Carbenicillin by injection (e.g., Geopen) or 
  <LI>Dipyridamole (e.g., Persantine) or 
  <LI>Divalproex (e.g., Depakote) or 
  <LI>Heparin (e.g., Hepalean, Liquaemin) or 
  <LI>Pentoxifylline (e.g., Trental) or 
  <LI>Plicamycin (e.g., Mithracin) or 
  <LI>Sulfinpyrazone (e.g., Anturane) or 
  <LI>Ticarcillin (e.g., Ticar) or 
  <LI>Thrombolytic agents or 
  <LI>Valproic acid (e.g., Depakene)—Any of these medicines may increase the 
  chance of bleeding, especially when used with cefamandole, cefoperazone, or 
  cefotetan </LI></UL>
<UL>
  <LI>Diuretics, potent such asFurosemide (e.g., Lasix)— use with cefuroxime may 
  cause higher blood levels of cefuroxime and result in increased side effects 
  </LI></UL>
<UL>
  <LI>Iron—Iron supplements, including multivitamins that contain iron, may 
  decrease the effect of cefdinir. However, iron-fortified infant formula does 
  not decrease the effect of cefdinir </LI></UL>
<UL>
  <LI>Probenecid (e.g., Benemid) (except cefoperazone, ceftazidime, or 
  ceftriaxone)—Probenecid increases the blood level of many cephalosporins. 
  Although probenecid may be given with a cephalosporin by your doctor purposely 
  to increase the blood level to treat some infections, in other cases this 
  effect may be unwanted and may increase the chance of side effects </LI></UL>
<P></P></DIV>
<DIV class=minusOne><STRONG>Other medical problems—</STRONG>The presence of 
other medical problems may affect the use of cephalosporins. Make sure you tell 
your doctor if you have any other medical problems, especially: 
<UL>
  <LI>Bleeding problems, history of (cefamandole, cefditoren, cefoperazone, and 
  cefotetan only)—These medicines may increase the chance of bleeding </LI></UL>
<UL>
  <LI>Carnitine, low levels—Cefditoren may cause carnitine levels to decrease 
  further. </LI></UL>
<UL>
  <LI>Kidney disease—Some cephalosporins need to be given at a lower dose to 
  people with kidney disease. Also, cephalothin, and cefuroxime especially, may 
  increase the chance of kidney damage </LI></UL>
<UL>
  <LI>Liver disease (cefoperazone and cefuroxime)—Cefoperazone needs to be given 
  at a lower dose to people with liver disease. Condition may be worsened by 
  cefuroxime use. </LI></UL>
<UL>
  <LI>Phenylketonuria—Cefprozil oral suspension contains phenylalanine </LI></UL>
<UL>
  <LI>Poor nutritional status—these may be worsened by cefuroxime and you may 
  need to have vitamin K </LI></UL>
<UL>
  <LI>Stomach or gastrointestinal disease, history of (especially colitis, 
  including colitis caused by antibiotics, or enteritis)—Cephalosporins may 
  cause colitis in some patients </LI></UL></DIV><BR><BR><A name=SXX14></A>
<H4>Proper Use of This Medicine<A class=return 
href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#skip">Return 
to top</A> </H4>
<DIV class=minusOne>
<P>Cephalosporins may be taken on a full or empty stomach. If this medicine 
upsets your stomach, it may help to take it with food.
<P>Cefaclor extended-release tablets, cefditoren, cefpodoxime, and cefuroxime 
axetil should be taken with food to increase absorption of the medicine. 
Ceftibuten oral suspension should be taken on an empty stomach, at least 2 hours 
before or 1 hour after a meal.
<P>For patients taking the <EM>oral liquid</EM> form of this medicine: 
<UL>
  <LI>This medicine is to be taken by mouth. Use a specially marked measuring 
  spoon or other device to measure each dose accurately. The average household 
  teaspoon may not hold the right amount of liquid. 
  <LI>Do not use after the expiration date on the label since the medicine may 
  not work properly after that date. Check with your pharmacist if you have any 
  questions about this. </LI></UL>
<P>To help clear up your infection completely, <EM>keep taking this medicine for 
the full time of treatment</EM>, even if you begin to feel better after a few 
days. <EM>If you have a “strep” infection, you should keep taking this medicine 
for at least 10 days. This is especially important in “strep” infections since 
serious heart or kidney problems could develop later</EM> if your infection is 
not cleared up completely. Also, if you stop taking this medicine too soon, your 
symptoms may return.
<P>This medicine works best when there is a constant amount in the blood or 
urine. <EM>To help keep the amount constant, do not miss any doses. Also, it is 
best to take the doses at evenly spaced times, day and night</EM>. For example, 
if you are to take four doses a day, the doses should be spaced about 6 hours 
apart. If this interferes with your sleep or other daily activities, or if you 
need help in planning the best times to take your medicine, check with your 
health care professional.
<P><STRONG>Dosing—</STRONG>
<P>The dose of these medicines will be different for different patients. 
<EM>Follow your doctor's orders or the directions on the label</EM>. The 
following information includes only the average doses of these medicines. Your 
dose may be different if you have kidney disease. <EM>If your dose is different, 
do not change it</EM> unless your doctor tells you to do so.
<P>The number of capsules or tablets or teaspoonfuls of suspension that you take 
depends on the strength of the medicine. Also, <EM>the number of doses you take 
each day, the time allowed between doses, and the length of time you take the 
medicine depend on the medical problem for which you are taking a 
cephalosporin</EM>. 
<UL><LH><EM>For cefaclor</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>capsule</I> or <I>oral suspension</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—250 to 500 milligrams (mg) every eight hours. 
      <LI>Infants and children 1 month of age and older—6.7 to 13.4 mg per 
      kilogram (kg) (3.04 to 6.09 mg per pound) of body weight every eight 
      hours, or 10 to 20 mg per kg (4.54 to 9.09 mg per pound) of body weight 
      every twelve hours. </LI></UL>
    <LI>For <I>extended-release tablet</I> dosage form: 
    <UL>
      <LI>Adults and teenagers 16 years of age and older—375 to 500 mg every 
      twelve hours for seven to ten days. 
      <LI>Children up to 16 years of age—Use and dose must be determined by your 
      doctor. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefadroxil</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>oral</I> dosage forms (capsules, oral suspension, or tablets): 
    <UL>
      <LI>Adults and teenagers—500 milligrams (mg) or 1 gram every twelve hours, 
      or 1 or 2 grams once a day. 
      <LI>Children—15 mg per kilogram (kg) (6.81 mg per pound) of body weight 
      every twelve hours, or 30 mg per kg (13.63 mg per pound) of body weight 
      once a day. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefamandole</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—500 milligrams (mg) to 2 grams every four to 
      eight hours, injected into a muscle or vein. 
      <LI>Infants and children 1 month of age and older—8.3 to 50 mg per 
      kilogram (kg) (3.77 to 22.72 mg per pound) of body weight every four to 
      eight hours, injected into a muscle or vein. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefazolin</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—250 milligrams (mg) to 1.5 grams every six to 
      twelve hours, injected into a muscle or vein. 
      <LI>Infants and children 1 month of age and older—6.25 to 25 mg per 
      kilogram (kg) (2.84 to 11.36 mg per pound) of body weight every six hours, 
      or 8.3 to 33.3 mg per kg (3.77 to 15.13 mg per pound) of body weight every 
      eight hours, injected into a muscle or vein. 
      <LI>Newborns—20 mg per kg (9.09 mg per pound) of body weight every eight 
      to twelve hours, injected into a vein. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefdinir</EM> </LH>
  <LI>For bacterial infections:
  <UL>
    <LI>For <I>capsule or oral suspension</I>dosage form:
    <UL>
      <LI>Adults and teenagers—300 milligrams (mg) ever twelve hours or 600 mg 
      once a day for 5 to 10 days. 
      <LI>Infants and children 6 months of age and older—7 milligrams (mg) per 
      kilogram (3.18 mg per pound) of body weight every twelve hours or 14 mg 
      per kilogram (6.36 mg per pound) once a day for 5 to 10 days. 
  </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefditoren</EM> </LH>
  <LI>For acute bacterial bronchitis
  <UL>
    <LI>For <I>tablets</I> dosage form:
    <UL>
      <LI>Adults and children 12 years of age and older—400 milligrams (mg) 
      twice a day for 10 days 
      <LI>Children under 12 years of age—Dose must be determined by your doctor 
      </LI></UL></LI></UL>
  <LI>For bacterial throat infections or tonsillitis:
  <UL>
    <LI>For <I>tablets</I> dosage form:
    <UL>
      <LI>Adults and children 12 years of age and older—200 milligrams (mg) 
      twice a day for 10 days 
      <LI>Children under 12 years of age—Dose must be determined by your doctor 
      </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefepime</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—500 milligrams to 2 grams every eight to twelve 
      hours, injected into a muscle or vein, for seven to ten days. 
      <LI>Infants and children 2 months to 16 years of age—50 milligrams per 
      kilogram body weight injected into muscle or vein, every eight to twelve 
      hours, for seven to ten days. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefixime</EM> </LH>
  <TABLE border=1>
    <TBODY>
    <TR>
      <TD class=minusOne align=middle bgColor=#cfcfcf>
        <P align=center>Note:</P></TD>
      <TD class=minusOne align=left>
        <P align=left>Was withdrawn from the U.S. market by Wyeth in October 
        2002</P></TD></TR></TBODY></TABLE>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>oral</I> dosage forms (oral suspension or tablets): 
    <UL>
      <LI>Adults and teenagers—200 milligrams (mg) every twelve hours, or 400 mg 
      once a day. Gonorrhea is treated with a single, oral dose of 400 mg. 
      <LI>Children 6 months to 12 years of age—4 mg per kilogram (kg) (1.81 mg 
      per pound) of body weight every twelve hours, or 8 mg per kg (3.63 mg per 
      pound) of body weight once a day. 
      <LI>Infants up to 6 months of age—Use and dose must be determined by your 
      doctor. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefonicid</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—500 milligrams (mg) to 2 grams every twenty-four 
      hours, injected into a muscle or vein. 
      <LI>Children—Use and dose must be determined by your doctor. 
  </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefoperazone</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—1 to 6 grams every twelve hours, or 2 to 4 grams 
      every eight hours, injected into a muscle or vein. 
      <LI>Children—Use and dose must be determined by your doctor. 
  </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefotaxime</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—1 to 2 grams every four to twelve hours, injected 
      into a muscle or vein. Gonorrhea is usually treated with a single dose of 
      500 milligrams (mg) or 1 gram, injected into a muscle. 
      <LI>Children over 50 kg of body weight (110 pounds)—1 to 2 grams every 
      four to twelve hours, injected into a muscle or vein. 
      <LI>Infants and children 1 month of age and older and up to 50 kg of body 
      weight (110 pounds)—8.3 to 30 mg per kg (3.77 to 13.63 mg per pound) of 
      body weight every four hours, or 12.5 to 45 mg per kg (5.68 to 20.45 mg 
      per pound) of body weight every six hours, injected into a muscle or vein. 

      <LI>Newborns 1 to 4 weeks of age—50 mg per kg (22.72 mg per pound) of body 
      weight every eight hours, injected into a vein. 
      <LI>Newborns up to 1 week of age—50 mg per kilogram (kg) (22.72 mg per 
      pound) of body weight every twelve hours, injected into a vein. 
    </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefotetan</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—500 milligrams to 3 grams every twelve hours, or 
      1 or 2 grams every twenty-four hours, injected into a muscle or vein. 
      <LI>Children—Use and dose must be determined by your doctor. 
  </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefoxitin</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—1 to 3 grams every four to eight hours, injected 
      into a vein. 
      <LI>Infants and children 3 months of age and older—13.3 to 26.7 milligrams 
      (mg) per kilogram (kg) (6.04 to 12.13 mg per pound) of body weight every 
      four hours, or 20 to 40 mg per kg (9.09 to 18.18 mg per pound) of body 
      weight every six hours, injected into a vein. 
      <LI>Infants 1 to 3 months of age—20 to 40 mg per kg (9.09 to 18.18 mg per 
      pound) of body weight every six to eight hours, injected into a vein. 
      <LI>Newborns 1 to 4 weeks of age—20 to 40 mg per kg (9.09 to 18.18 mg per 
      pound) of body weight every eight hours, injected into a vein. 
      <LI>Premature infants weighing 1500 grams and over to newborns up to 1 
      week of age—20 to 40 mg per kg (9.09 to 18.18 mg per pound) of body weight 
      every twelve hours, injected into a vein. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefpodoxime</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>oral</I> dosage forms (oral suspension or tablets): 
    <UL>
      <LI>Adults and teenagers—100 to 400 milligrams (mg) every twelve hours for 
      five to fourteen days. Gonorrhea is treated with a single, oral dose of 
      200 mg. 
      <LI>Infants and children 5 months to 12 years of age—5 mg per kilogram 
      (kg) (2.27 mg per pound) of body weight every twelve hours for five to ten 
      days, or 10 mg per kg (4.54 mg per pound) of body weight every twenty-four 
      hours for ten days. 
      <LI>Infants up to 5 months of age—Use and dose must be determined by your 
      doctor. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefprozil</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>oral</I> dosage forms (oral suspension or tablets): 
    <UL>
      <LI>Adults and teenagers—250 or 500 milligrams (mg) every twelve to 
      twenty-four hours for ten days. 
      <LI>Children 2 to 12 years of age—7.5 to 20 mg per kilogram (kg) (3.4 to 
      9.09 mg per pound) of body weight every twelve to twenty-four hours for 
      ten days. 
      <LI>Infants and children 6 months to 12 years of age—7.5 to 15 mg per kg 
      (3.4 to 6.81 mg per pound) of body weight every twelve hours for ten days. 

      <LI>Infants up to 6 months of age—Use and dose must be determined by your 
      doctor. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For ceftazidime</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—250 milligrams (mg) to 2 grams every eight to 
      twelve hours, injected into a muscle or vein. Patients with cystic 
      fibrosis may receive 30 to 50 mg per kilogram (kg) (13.63 to 22.72 mg per 
      pound) of body weight every eight hours, injected into a vein. 
      <LI>Infants and children 1 month to 12 years of age—30 to 50 mg per kg 
      (13.63 to 22.72 mg per pound) of body weight every eight hours, injected 
      into a vein. 
      <LI>Newborns up to 4 weeks of age—30 mg per kg (13.63 mg per pound) of 
      body weight every twelve hours, injected into a vein. 
</LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For ceftibuten</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>oral</I> dosage forms (capsules or oral suspension): 
    <UL>
      <LI>Adults and teenagers—400 milligrams (mg) once a day for ten days. 
      <LI>Infants and children 6 months to 12 years of age—9 mg per kilogram 
      (4.09 mg per pound) of body weight once a day for ten days. 
      <LI>Infants up to 6 months of age—Use and dose must be determined by your 
      doctor. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For ceftizoxime</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—500 milligrams (mg) to 4 grams every eight to 
      twelve hours, injected into a muscle or vein. Gonorrhea is treated with a 
      single dose of 1 gram, injected into a muscle. 
      <LI>Infants and children 6 months of age and older—50 mg per kilogram 
      (22.72 mg per pound) of body weight every six to eight hours, injected 
      into a muscle or vein. 
      <LI>Infants up to 6 months of age—Use and dose must be determined by your 
      doctor. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For ceftriaxone</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—1 to 2 grams every twenty-four hours, or 500 
      milligrams (mg) to 1 gram every twelve hours, injected into a muscle or 
      vein. Gonorrhea is treated with a single 250-mg dose, injected into a 
      muscle. 
      <LI>Infants and children—25 to 37.5 mg per kilogram (kg) (11.36 to 17.04 
      mg per pound) of body weight every twelve hours, or 50 to 75 mg per kg 
      (22.72 to 34.09 mg per pound) of body weight once a day, injected into a 
      muscle or vein. Meningitis is treated with an initial dose of 100 mg per 
      kg, then 100 mg per kg once a day or 50 mg per kg two times a day. 
    </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cefuroxime</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>oral suspension</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—The oral suspension is usually used only for 
      children. Refer to the dosing for cefuroxime tablets. 
      <LI>Infants and children 3 months to 12 years of age—10 to 15 milligrams 
      (mg) per kilogram (kg) (4.54 to 6.81 mg per pound) of body weight every 
      twelve hours for ten days. </LI></UL>
    <LI>For <I>tablet</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—250 to 500 mg every twelve hours. Gonorrhea is 
      treated with a single, oral 1-gram dose. 
      <LI>Children up to 12 years of age who can swallow tablets whole—250 mg 
      every twelve hours for ten days. </LI></UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—750 mg to 3 grams every six to eight hours 
      usually for 5 to 14 days, injected into a muscle or vein. Gonorrhea is 
      treated with a single dose of 1.5 grams, injected into a muscle; the total 
      1.5-gram dose is divided into two doses and injected into muscles at two 
      separate places on the body, and given along with a single, oral 1-gram 
      dose of probenecid. 
      <LI>Infants and children 1 month of age and older—12.5 to 150 mg per kg 
      (5.68 to mg per pound) of body weight every six to eight hours, injected 
      into a muscle or vein. 
      <LI>Newborns—10 to 100 mg per kg (4.54 to 45.5 mg mg per pound) of body 
      weight every eight to twelve hours, injected into a vein. 
  </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cephalexin</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>oral</I> dosage forms (capsules, oral suspension, or tablets): 
    <UL>
      <LI>Adults and teenagers—250 milligrams (mg) to 1 gram every six to twelve 
      hours. 
      <LI>Children 40 kg (88 pounds) of body weight and over—250 mg to 1 gram 
      every six to twelve hours. 
      <LI>Children 1 year of age and older and up to 40 kg (88 pounds) of body 
      weight—6.25 to 25 mg per kilogram (kg) (2.84 to 11.36 mg per pound) of 
      body weight every six hours, or 12.5 to 50 mg per kg (5.68 to 22.72 mg per 
      pound) of body weight every twelve hours. 
      <LI>Infants and children 1 month to 1 year of age—6.25 to 12.5 mg per kg 
      (2.84 to 5.68 mg per pound) of body weight every six hours. 
  </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cephalothin</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—500 milligrams (mg) to 2 grams every four to six 
      hours, injected into a muscle or vein. 
      <LI>Children—13.3 to 26.6 mg per kilogram (kg) (6.04 to 12.09 mg per 
      pound) of body weight every four hours, or 20 to 40 mg per kg (9.09 to 
      18.18 mg per pound) of body weight every six hours, injected into a muscle 
      or vein. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cephapirin</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>injection</I> dosage form: 
    <UL>
      <LI>Adults and teenagers—500 milligrams (mg) to 1 gram every four to six 
      hours, injected into a muscle or vein. 
      <LI>Infants and children 3 months of age and older—10 to 20 mg per 
      kilogram (kg) (4.54 to 9.09 mg per pound) of body weight every six hours, 
      injected into a muscle or vein. </LI></UL></LI></UL></LI></UL>
<UL><LH><EM>For cephradine</EM> </LH>
  <LI>For bacterial infections: 
  <UL>
    <LI>For <I>oral</I> dosage forms (capsules or oral suspension): 
    <UL>
      <LI>Adults and teenagers—250 milligrams (mg) to 1 gram every six to twelve 
      hours. 
      <LI>Infants and children 9 months of age and older—6.25 mg to 1 gram per 
      kilogram (kg) (2.84 to 454 mg per pound) of body weight every six hours, 
      or 12.5 to 50 mg per kg (5.68 to 22.72 mg per pound) of body weight every 
      twelve hours. </LI></UL></LI></UL></LI></UL>
<P><STRONG>Missed dose—</STRONG>
<P>If you miss a dose of this medicine, take it as soon as possible. This will 
help to keep a constant amount of medicine in the blood or urine. However, if it 
is almost time for your next dose, skip the missed dose and go back to your 
regular dosing schedule. Do not double doses.
<P><STRONG>Storage—</STRONG>
<P>To store this medicine: 
<UL>
  <LI>Keep out of the reach of children. 
  <LI>Store away from heat and direct light. 
  <LI>Do not store the capsule or tablet form of this medicine in the bathroom, 
  near the kitchen sink, or in other damp places. Heat or moisture may cause the 
  medicine to break down. 
  <LI>Store the oral liquid form of most cephalosporins in the refrigerator 
  because heat will cause this medicine to break down. However, keep the 
  medicine from freezing. Follow the directions on the label. Cefixime oral 
  suspension (<I>Suprax</I>) , cefuroxime axetil oral suspension 
  (<I>Ceftin</I>), and cefdinir oral suspension (<I> Omnicef</I>) do not need to 
  be refrigerated. 
  <LI>Do not keep outdated medicine or medicine no longer needed. Be sure that 
  any discarded medicine is out of the reach of children. </LI></UL></DIV><BR><A 
name=SXX18></A>
<H4>Precautions While Using This Medicine<A class=return 
href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#skip">Return 
to top</A> </H4>
<DIV class=minusOne>
<P>If your symptoms do not improve within a few days, or if they become worse, 
check with your doctor.
<P><EM>For patients with diabetes</EM>: 
<UL>
  <LI><I>This medicine may cause false test results with some urine sugar 
  tests</I>. Check with your doctor before changing your diet or the dosage of 
  your diabetes medicine. </LI></UL>
<P><EM>For patients with phenylketonuria (PKU)</EM>: 
<UL>
  <LI>Cefprozil oral suspension ( <I>Cefzil</I>) contains phenylalanine. Check 
  with your doctor before taking this medicine. </LI></UL>
<P>In some patients, cephalosporins may cause diarrhea: 
<UL>
  <LI>Severe diarrhea may be a sign of a serious side effect. <I>Do not take any 
  diarrhea medicine without first checking with your doctor </I>. Diarrhea 
  medicines may make your diarrhea worse or make it last longer. 
  <LI>For mild diarrhea, diarrhea medicine containing kaolin or attapulgite 
  (e.g., <I>Kaopectate</I> tablets, <I>Diasorb</I>) may be taken. However, other 
  kinds of diarrhea medicine should not be taken. They may make your diarrhea 
  worse or make it last longer. 
  <LI>If you have any questions about this or if mild diarrhea continues or gets 
  worse, check with your health care professional. </LI></UL>
<P>For patients receiving <EM>cefamandole, cefoperazone, or cefotetan by 
injection</EM>: 
<UL>
  <LI>Drinking alcoholic beverages or taking other alcohol-containing 
  preparations (for example, elixirs, cough syrups, tonics, or injections of 
  alcohol) while receiving these medicines may cause problems. The problems may 
  occur if you consume alcohol even several days after you stop taking the 
  cephalosporin. Drinking alcoholic beverages may result in increased side 
  effects such as abdominal or stomach cramps, nausea, vomiting, headache, 
  fainting, fast or irregular heartbeat, difficult breathing, sweating, or 
  redness of the face or skin. These effects usually start within 15 to 30 
  minutes after you drink alcohol and may not go away for up to several hours. 
  Therefore, <I>you should not drink alcoholic beverages or take other 
  alcohol-containing preparations while you are receiving these medicines and 
  for several days after stopping them</I>. </LI></UL></DIV><BR><A name=SXX19></A>
<H4>Side Effects of This Medicine<A class=return 
href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#skip">Return 
to top</A> </H4>
<DIV class=minusOne>
<P>Along with its needed effects, a medicine may cause some unwanted effects. 
Although not all of these side effects may occur, if they do occur they may need 
medical attention.</P>
<P><I>Check with your doctor immediately</I> if any of the following side 
effects occur:</P>
<UL>
  <LI><EM>More common</EM> 
  <UL>
    <LI>Black, tarry stools;&nbsp; chest pain;&nbsp; chills;&nbsp; cough;&nbsp; 
    fever;&nbsp; painful or difficult urination;&nbsp; shortness of 
    breath;&nbsp; sore throat;&nbsp; sores, ulcers, or white spots on lips or in 
    mouth;&nbsp; swollen glands;&nbsp; unusual bleeding or bruising (more common 
    for cefamandole, cefoperazone, cefotetan and cefuroxime) ;&nbsp; unusual 
    tiredness or weakness&nbsp; </LI></UL><BR></LI></UL>
<UL>
  <LI><EM>Less common or rare</EM> 
  <UL>
    <LI>Abdominal or stomach cramps and pain (severe);&nbsp; abdominal 
    tenderness;&nbsp; diarrhea (watery and severe, which may also be 
    bloody);&nbsp; hives or welts, itching redness of skin, or skin rash;&nbsp; 
    pain, redness and swelling at site of injection;&nbsp; peeling of 
    skin;&nbsp; seizures&nbsp; </LI></UL><BR>
  <P>Some of these side effects also may occur up to several weeks after you 
  stop taking this medicine.</P></LI></UL>
<UL>
  <LI><EM>Rare</EM> 
  <UL>
    <LI>Blistering, peeling, or loosening of skin;&nbsp; decrease in urine 
    output;&nbsp; hearing loss (more common with cefuroxime treatment for 
    meningitis);&nbsp; joint pain;&nbsp; loss of appetite, nausea, or vomiting 
    (more common with ceftriaxone);&nbsp; red or irritated eyes;&nbsp; trouble 
    in breathing;&nbsp; yellowing of the eyes or skin&nbsp; </LI></UL><BR></LI></UL>
<P>Other side effects may occur that usually do not need medical attention. 
These side effects may go away during treatment as your body adjusts to the 
medicine. However, check with your doctor if any of the following side effects 
continue or are bothersome:</P>
<UL>
  <LI><EM>More common (less common with some cephalosporins)</EM> 
  <UL>
    <LI>Diarrhea (mild);&nbsp; headache;&nbsp; sore mouth or tongue;&nbsp; 
    stomach cramps (mild);&nbsp; vaginal itching or discharge&nbsp; 
  </LI></UL><BR></LI></UL>
<P>Other side effects not listed above may also occur in some patients. If you 
notice any other effects, check with your doctor.</P></DIV><BR><A name=SXX></A>
<H4>Additional Information<A class=return 
href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#skip">Return 
to top</A> </H4>
<DIV class=minusOne>
<P>Once a medicine has been approved for marketing for a certain use, experience 
may show that it is also useful for other medical problems. Although these uses 
are not included in product labeling, cephalosporins are used in certain 
patients with the following medical conditions:
<UL>
  <LI>Amoxicillin-resistant sinusitis (treatment)—Cefaclor 
  <LI>Bacterial endocarditis (Prophylaxis)—Cefadroxil, cefazolin, and cephalexin 

  <LI>Melioidosis (treatment)—Ceftazidime </LI></UL>Products containing cefixime 
were withdrawn from the U.S. market by Wyeth in October 2002
<P>Other than the above information, there is no additional information relating 
to proper use, precautions, or side effects for these uses.</P></DIV><BR><A 
name=Brands></A>
<H4>Brand Names<A class=return 
href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#skip">Return 
to top</A> </H4>
<DIV class=minusOne>
<P>Some commonly used brand names are:</P>
<P><STRONG>In the U.S.— </STRONG></P>
<TABLE width="100%" border=0>
  <TBODY>
  <TR vAlign=top>
    <TD class=minusOne vAlign=top width="50%">
      <TABLE width="100%" border=0>
        <TBODY>
        <TR vAlign=top>
          <TD class=minusOne vAlign=top>
            <UL>
              <LI>Ancef<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211904"><SUP>4</SUP></A>
              <LI>Ceclor<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211901"><SUP>1</SUP></A>
              <LI>Ceclor CD<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211901"><SUP>1</SUP></A>
              <LI>Cedax<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211916"><SUP>16</SUP></A>
              <LI>Cefadyl<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211922"><SUP>22</SUP></A>
              <LI>Cefditoren<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211977"><SUP>77</SUP></A>
              <LI>Cefizox<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211917"><SUP>17</SUP></A>
              <LI>Cefobid<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211909"><SUP>9</SUP></A>
              <LI>Cefotan<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211911"><SUP>11</SUP></A>
              <LI>Ceftin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211919"><SUP>19</SUP></A>
              <LI>Cefzil<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211914"><SUP>14</SUP></A>
              <LI>Ceptaz<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211915"><SUP>15</SUP></A>
              <LI>Claforan<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211910"><SUP>10</SUP></A>
              <LI>Duricef<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211902"><SUP>2</SUP></A>
              <LI>Fortaz<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211915"><SUP>15</SUP></A></LI></UL></TD></TR></TBODY></TABLE></TD>
    <TD class=minusOne vAlign=top width="50%">
      <TABLE width="100%" border=0>
        <TBODY>
        <TR vAlign=top>
          <TD class=minusOne vAlign=top>
            <UL>
              <LI>Keflex<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211920"><SUP>20</SUP></A>
              <LI>Keftab<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211920"><SUP>20</SUP></A>
              <LI>Kefurox<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211919"><SUP>19</SUP></A>
              <LI>Kefzol<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211904"><SUP>4</SUP></A>
              <LI>Mandol<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211903"><SUP>3</SUP></A>
              <LI>Maxipime<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211906"><SUP>6</SUP></A>
              <LI>Mefoxin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211912"><SUP>12</SUP></A>
              <LI>Monocid<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211908"><SUP>8</SUP></A>
              <LI>Omnicef<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211905"><SUP>5</SUP></A>
              <LI>Rocephin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211918"><SUP>18</SUP></A>
              <LI>Tazicef<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211915"><SUP>15</SUP></A>
              <LI>Tazidime<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211915"><SUP>15</SUP></A>
              <LI>Vantin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211913"><SUP>13</SUP></A>
              <LI>Velosef<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211923"><SUP>23</SUP></A>
              <LI>Zinacef<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211919"><SUP>19</SUP></A></LI></UL></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>
<P><STRONG>In Canada— </STRONG></P>
<TABLE width="100%" border=0>
  <TBODY>
  <TR vAlign=top>
    <TD class=minusOne vAlign=top width="50%">
      <TABLE width="100%" border=0>
        <TBODY>
        <TR vAlign=top>
          <TD class=minusOne vAlign=top>
            <UL>
              <LI>Ancef<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211904"><SUP>4</SUP></A>
              <LI>Apo-Cefaclor<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211901"><SUP>1</SUP></A>
              <LI>Apo-Cephalex<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211920"><SUP>20</SUP></A>
              <LI>Ceclor<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211901"><SUP>1</SUP></A>
              <LI>Cefizox<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211917"><SUP>17</SUP></A>
              <LI>Cefotan<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211911"><SUP>11</SUP></A>
              <LI>Ceftin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211919"><SUP>19</SUP></A>
              <LI>Cefzil<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211914"><SUP>14</SUP></A>
              <LI>Ceporacin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211921"><SUP>21</SUP></A>
              <LI>Ceptaz<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211915"><SUP>15</SUP></A>
              <LI>Claforan<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211910"><SUP>10</SUP></A>
              <LI>Duricef<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211902"><SUP>2</SUP></A>
              <LI>Fortaz<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211915"><SUP>15</SUP></A>
              <LI>Keflex<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211920"><SUP>20</SUP></A></LI></UL></TD></TR></TBODY></TABLE></TD>
    <TD class=minusOne vAlign=top width="50%">
      <TABLE width="100%" border=0>
        <TBODY>
        <TR vAlign=top>
          <TD class=minusOne vAlign=top>
            <UL>
              <LI>Keflin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211921"><SUP>21</SUP></A>
              <LI>Kefurox<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211919"><SUP>19</SUP></A>
              <LI>Kefzol<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211904"><SUP>4</SUP></A>
              <LI>Mandol<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211903"><SUP>3</SUP></A>
              <LI>Maxipime<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211906"><SUP>6</SUP></A>
              <LI>Mefoxin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211912"><SUP>12</SUP></A>
              <LI>Novo-Lexin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211920"><SUP>20</SUP></A>
              <LI>Nu-Cephalex<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211920"><SUP>20</SUP></A>
              <LI>PMS-Cephalexin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211920"><SUP>20</SUP></A>
              <LI>Rocephin<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211918"><SUP>18</SUP></A>
              <LI>Suprax<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211907"><SUP>7</SUP></A>
              <LI>Tazidime<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211915"><SUP>15</SUP></A>
              <LI>Zinacef<A 
              href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#GXXg20211919"><SUP>19</SUP></A></LI></UL></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></DIV><BR>
<TABLE border=1>
  <TBODY>
  <TR>
    <TD class=minusOne align=middle bgColor=#cfcfcf>
      <P align=center>Note:</P></TD>
    <TD class=minusOne align=left>For quick reference, the following 
      cephalosporins are numbered to match the corresponding brand 
  names.</TD></TR></TBODY></TABLE>
<DIV class=minusOne></DIV>
<TABLE cellSpacing=10 width="100%">
  <TBODY>
  <TR vAlign=top>
    <TD class=minusOne colSpan=2>This information applies to the following 
      medicines:</TD></TR>
  <TR vAlign=top>
  <TR>
    <TD vAlign=top align=left width="50%">
      <TABLE cellSpacing=10 width="100%">
        <TBODY>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">1.&nbsp; <A 
            name=GXXg20211901></A>Cefaclor (SEF-a-klor)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fgau20211953">‡</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">2.&nbsp; <A 
            name=GXXg20211902></A>Cefadroxil (sef-a-DROX-ill)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fgau20211953">‡</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">3.&nbsp; <A 
            name=GXXg20211903></A>Cefamandole (sef-a-MAN-dole)</TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">4.&nbsp; <A 
            name=GXXg20211904></A>Cefazolin (sef-A-zoe-lin)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fgau20211953">‡</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">5.&nbsp; <A 
            name=GXXg20211905></A>Cefdinir (sef–DI–neer)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fgau20211953">‡</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">6.&nbsp; <A 
            name=GXXg20211906></A>Cefepime (SEF-e-pim)</TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">7.&nbsp; <A 
            name=GXXg20211907></A>Cefixime (sef-IX-eem)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fau20211951">*</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">77.&nbsp; <A 
            name=GXXg20211977></A>Cefditoren (sef-da-TOR-en)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fac20211952">†</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">8.&nbsp; <A 
            name=GXXg20211908></A>Cefonicid (se-FON-i-sid)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fac20211952">†</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">9.&nbsp; <A 
            name=GXXg20211909></A>Cefoperazone (sef-oh-PER-a-zone)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fac20211952">†</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">10.&nbsp; <A 
            name=GXXg20211910></A>Cefotaxime (sef-oh-TAKS-eem)</TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">11.&nbsp; <A 
            name=GXXg20211911></A>Cefotetan 
    (SEF-oh-tee-tan)</TD></TR></TBODY></TABLE></TD>
    <TD vAlign=top align=left width="50%">
      <TABLE cellSpacing=10 width="100%">
        <TBODY>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">12.&nbsp; <A 
            name=GXXg20211912></A>Cefoxitin (se-FOX-i-tin)</TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">13.&nbsp; <A 
            name=GXXg20211913></A>Cefpodoxime (sef-pode-OX-eem)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fac20211952">†</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">14.&nbsp; <A 
            name=GXXg20211914></A>Cefprozil (sef-PROE-zil)</TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">15.&nbsp; <A 
            name=GXXg20211915></A>Ceftazidime (SEF-tay-zi-deem)</TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">16.&nbsp; <A 
            name=GXXg20211916></A>Ceftibuten (sef-TYE-byoo-ten)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fac20211952">†</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">17.&nbsp; <A 
            name=GXXg20211917></A>Ceftizoxime (sef-ti-ZOX-eem)</TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">18.&nbsp; <A 
            name=GXXg20211918></A>Ceftriaxone (sef-trye-AX-one)</TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">19.&nbsp; <A 
            name=GXXg20211919></A>Cefuroxime (se-fyoor-OX-eem)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fgau20211953">‡</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">20.&nbsp; <A 
            name=GXXg20211920></A>Cephalexin (sef-a-LEX-in)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fgau20211953">‡</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">21.&nbsp; <A 
            name=GXXg20211921></A>Cephalothin (sef-A-loe-thin)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fau20211951">*</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">22.&nbsp; <A 
            name=GXXg20211922></A>Cephapirin (sef-a-PYE-rin)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fac20211952">†</A></TD></TR>
        <TR>
          <TD class=minusOne vAlign=top align=left width="100%">23.&nbsp; <A 
            name=GXXg20211923></A>Cephradine (SEF-ra-deen)<A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fgau20211953">‡</A><A 
            href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#fac20211952">†</A></TD></TR></TBODY></TABLE></TD></TR></TR>
  <TR>
    <TD class=minusOne width="50%" bgColor=#dfdfdf><A name=fgau20211953>‡ 
      &nbsp;Generic name product may be available in the U.S.</A></TD></TR>
  <TR>
    <TD class=minusOne width="50%" bgColor=#dfdfdf><A name=gac20211954>§ 
      &nbsp;Generic name product may be available in Canada</A></TD></TR>
  <TR>
    <TD class=minusOne width="50%" bgColor=#dfdfdf><A name=fau20211951>* 
      &nbsp;Not commercially available in the U.S.</A></TD></TR>
  <TR>
    <TD class=minusOne width="50%" bgColor=#dfdfdf><A name=fac20211952>† 
      &nbsp;Not commercially available in Canada</A></TD></TR></TBODY></TABLE><A 
name=CATEGORY_SEC></A>
<H4>Category<A class=return 
href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202119.html#skip">Return 
to top</A> </H4>
<DIV class=minusOne>
<UL>
  <LI><STRONG>Antibacterial, systemic</STRONG>&nbsp;--Cefaclor; Cefadroxil; 
  Cefamandole ; Cefazolin; Cefdinir; Cefditoren; Cefepime; Cefixime; Cefonicid; 
  Cefoperazone ; Cefotaxime; Cefotetan; Cefoxitin; Cefpodoxime; Cefprozil ; 
  Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime ; Cephalexin; 
  Cephalothin; Cephapirin; Cephradine</LI></UL></DIV>
<P></P>
<DIV class=minusOne>Revised: 11/17/2004</DIV><BR>
<DIV align=center>
<P class=minusOne><A 
href="http://www.nlm.nih.gov/medlineplus/micromedexdisclaimer.html">Thomson 
Micromedex, Inc. Disclaimer</A></P>
<P class=minusTwo>Copyright © 2006 Thomson Healthcare. All rights reserved. USP 
DI ® and Advice for the Patient ® are registered trademarks of USP used under 
license to Thomson MICROMEDEX. Information is for End User's use only and may 
not be sold, redistributed or otherwise used for commercial purposes.</P></DIV>
<TABLE class=footer cellSpacing=0 cellPadding=0>
  <TBODY>
  <TR>
    <TD class=tabLinks colSpan=2><A href="http://medlineplus.gov/">Home</A> | 
      <A href="http://www.nlm.nih.gov/medlineplus/healthtopics.html">Health 
      Topics</A> | <A 
      href="http://www.nlm.nih.gov/medlineplus/druginformation.html">Drugs &amp; 
      Supplements</A> | <A 
      href="http://www.nlm.nih.gov/medlineplus/encyclopedia.html">Encyclopedia</A> 
      | <A 
      href="http://www.nlm.nih.gov/medlineplus/mplusdictionary.html">Dictionary</A> 
      | <A href="http://www.nlm.nih.gov/medlineplus/newsbydate.html">News</A> | 
      <A 
      href="http://www.nlm.nih.gov/medlineplus/directories.html">Directories</A> 
      | <A href="http://www.nlm.nih.gov/medlineplus/otherresources.html">Other 
      Resources</A></TD></TR>
  <TR class=footBody>
    <TD><A 
      href="http://www.nlm.nih.gov/medlineplus/copyright.html">Copyright</A> | 
      <A href="http://www.nlm.nih.gov/medlineplus/privacy.html">Privacy</A> | <A 
      href="http://www.nlm.nih.gov/medlineplus/accessibility.html">Accessibility</A> 
      | <A href="http://www.nlm.nih.gov/medlineplus/criteria.html">Quality 
      Guidelines</A> <BR><A onclick="openOutWin('')" 
      href="http://www.nlm.nih.gov/cgi/medlineplus/leavemedplus.pl?theURL=http%3A%2F%2Fwww%2Enlm%2Enih%2Egov" 
      target=TheNewWin>U.S. National Library of Medicine</A>, 8600 Rockville 
      Pike, Bethesda, MD 20894 <BR><A onclick="openOutWin('')" 
      href="http://www.nlm.nih.gov/cgi/medlineplus/leavemedplus.pl?theURL=http%3A%2F%2Fwww%2Enih%2Egov" 
      target=TheNewWin>National Institutes of Health</A> | <A 
      onclick="openOutWin('')" 
      href="http://www.nlm.nih.gov/cgi/medlineplus/leavemedplus.pl?theURL=http%3A%2F%2Fwww%2Ehhs%2Egov" 
      target=TheNewWin>Department of Health &amp; Human Services</A></TD>
    <TD class=updated>Page last updated: 23 January 2007 
</TD></TR></TBODY></TABLE></BODY></HTML>
